 |
| 17-Jun-13 | Reiterated |
Argus |
Buy |
$95 → $115 |
|
| 03-May-13 | Reiterated |
Mizuho |
Neutral |
$87 → $96 |
|
| 12-Apr-13 | Reiterated |
Deutsche Bank |
Hold |
$89 → $94 |
|
| 14-Feb-13 | Reiterated |
Argus |
Buy |
$87 → $95 |
|
| 06-Feb-13 | Reiterated |
Barclays |
Underweight |
$82 → $86 |
|
| 22-Jan-13 | Downgrade |
Mizuho |
Buy → Neutral |
$87 |
|
| 04-Jan-13 | Reiterated |
Deutsche Bank |
Hold |
$85 → $78 |
|
| 20-Nov-12 | Initiated |
Stifel Nicolaus |
Hold |
|
|
| 24-Sep-12 | Downgrade |
Barclays |
Equal Weight → Underweight |
$76 → $82 |
|
| 21-Jun-11 | Reiterated |
Argus |
Buy |
$90 → $96 |
|
| 28-Apr-11 | Reiterated |
Deutsche Bank |
Hold |
$86 → $88 |
|
| 25-Jan-11 | Reiterated |
Barclays Capital |
Equal Weight |
$78 → $85 |
|
| 18-Jan-11 | Reiterated |
Deutsche Bank |
Hold |
$79 → $86 |
|
| 16-Nov-10 | Initiated |
Canaccord Genuity |
Hold |
$85 |
|
| 10-Sep-10 | Initiated |
Caris & Company |
Average |
$74 |
|
| 20-Jul-10 | Reiterated |
Barclays Capital |
Equal Weight |
$85 → $78 |
|
| 20-Jul-10 | Downgrade |
CL King |
Strong Buy → Neutral |
|
|
| 24-Jun-10 | Reiterated |
Argus |
Buy |
$90 → $84 |
|
| 27-Apr-10 | Initiated |
Barclays Capital |
Equal Weight |
|
|
| 21-Apr-10 | Initiated |
RBC Capital Mkts |
Sector Perform |
|
|
|
|
| 19-Jun-13 01:40PM | BDX Teams Again With JDRF Zacks |
| 01:02PM | A Discounted Medical Equipment Play at Motley Fool |
| 08:00AM | New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research PR Newswire |
| 18-Jun-13 01:40PM | Cooper Hits 52-Week High Zacks |
| 08:30AM | JDRF extends collaboratoin with Becton Dickinson at theflyonthewall.com |
| 08:30AM | JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes PR Newswire |
| 17-Jun-13 05:16PM | Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate at Seeking Alpha |
| 02:01PM | Analysts: Stable DRAM Prices Will Benefit Micron and 3 More Research Notes to Browse Through at Wall St. Cheat Sheet |
| 02:00PM | Mindray to Takeover ZONARE Zacks |
| 13-Jun-13 07:01AM | SAP, Pfizer-Teva, FIFA, Agilent: Intellectual Property at Bloomberg |
| 12-Jun-13 09:20PM | Becton, Dickinson and Company Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 02:40 PM at Seeking Alpha |
| 11-Jun-13 02:40PM | Can New Management Drive New Growth At Techne? at Seeking Alpha |
| 10-Jun-13 02:00PM | Cooper Unveils MyDay Lenses Zacks |
| 08:45AM | Which Of The Russell 3000 Healthcare Companies Is Most Attractive To Dividend Investors? at Seeking Alpha |
| 07-Jun-13 10:32AM | Dividend Champions Smackdown XXXIX at Seeking Alpha |
| 08:00AM | Cooper Earnings Beat, Rev Misses Est Zacks |
| 06-Jun-13 04:00PM | BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference PR Newswire |
| 01:20PM | Bard Begins Lutonix BTK Trial Zacks |
| 12:51PM | Becton, Dickinson And Co. Dividend Stock Analysis at Seeking Alpha |
| 05-Jun-13 06:30PM | CR Bard Reiterated at Neutral Zacks |
| 01:40PM | PerkinElmer Releases New Apps Zacks |
| 04-Jun-13 02:10PM | BDX Rolls Out BD Neopak Zacks |
| 01:04PM | 5 Health Services Stocks Dragging The Industry Down at TheStreet |
| 09:53AM | Becton Dickinson Stock To Go Ex-dividend Tomorrow (BDX) at TheStreet |
| 08:00AM | BD and Heart to Heart International Continue Ongoing Collaboration to Help Improve Healthcare in Haiti with Third Volunteer Service Trip PR Newswire |
| 03-Jun-13 02:30PM | Amedisys Retains The Braff Group Zacks |
| 02:00PM | Cooper Agrees to Sell Aime Zacks |
| 10:33AM | Cash Dividend On The Way From Becton, Dickinson and Company (BDX) at Forbes |
| 08:00AM | New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery PR Newswire |
| 31-May-13 02:00PM | Investing For The Global Diabetes Epidemic at Investopedia |
| 11:34AM | Billionaire Richard Chiltons Bullish First Quarter Bets at Motley Fool |
| 30-May-13 02:00PM | Becton, Dickinson and Company Presents at 38th Annual Deutsche Bank Health Care Conference, May-30-2013 10:40 AM at Seeking Alpha |
| 28-May-13 05:27PM | How Can You Honestly Evaluate Your Trading Activity? at Seeking Alpha |
| 24-May-13 02:30PM | BD to Present at the Deutsche Bank 38th Annual Health Care Conference PR Newswire |
| 23-May-13 01:15PM | Patterson Cos Posts In-Line Earnings Zacks |
| 22-May-13 03:20PM | A Moderate-Risk, High-Reward Dividend Play at Seeking Alpha |
| 02:15PM | BSX Entangled in Patent Issues Zacks |
| 01:40PM | Wright Medical Stays Neutral Zacks |
| 08:00AM | BD Issues 2012 Sustainability Report PR Newswire |
| 21-May-13 02:00PM | THOR Downgraded to Underperform Zacks |
| 11:25AM | BD Board Declares Dividend PR Newswire |
| 20-May-13 02:10PM | FDA Nod for Thoratec Controller Zacks |
| 01:40PM | PKI Downgraded to Underperform Zacks |
| 01:21PM | July Options Now Available For Becton, Dickinson And Co. (BDX) at TheStreet |
| 19-May-13 10:05PM | The Top 35 Dividend Champions With Regard To Long-Term Stock Price Appreciation at Seeking Alpha |
| 17-May-13 05:21PM | Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds at Seeking Alpha |
| 01:03PM | 4 Stocks Driving The Health Services Industry Higher at TheStreet |
| 10:45AM | Wall Street Transcript Interview with Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd.: A Health Sciences Fund with a Long-Term Focus Wall Street Transcript |
| 16-May-13 07:49AM | Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co. Zacks |
| 15-May-13 01:04PM | BECTON DICKINSON & CO Financials EDGAR Online Financials |
| 06:02AM | Portfolio Review: Focused Investor LLC at Seeking Alpha |
| 14-May-13 06:00PM | Does the Healthcare Industry mean Stability? at Motley Fool |
| 05:03PM | LipoScience Gives Its Shareholders Chest Pains at Seeking Alpha |
| 13-May-13 04:16PM | The Best In An Expensive Sector at Motley Fool |
| 10-May-13 01:04PM | 5 Stocks Driving The Health Services Industry Higher at TheStreet |
| 11:00AM | Alere Beats Earnings Est, Turns to Profit Zacks |
| 09:58AM | Becton Dickinson Reaches New 52-Week High (BDX) at TheStreet |
| 07:33AM | Becton Dickinson upgraded to Outperform from Neutral at Macquarie at theflyonthewall.com |
| 09-May-13 08:45AM | DENTSPLY Misses Earnings Est; Outlook Down Zacks |
| 06:23AM | BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08-May-13 04:40PM | HSIC Misses Earnings Despite Y/Y Gain Zacks |
| 11:55AM | Recent Financials May Not Be Entirely Fair To Hologic at Investopedia |
| 07-May-13 01:40PM | Reiterate Becton Dickinson at Neutral Zacks |
| 12:24PM | This Large Cap Manufacturer Is a Steal Below Liquidation Value at Motley Fool |
| 04-May-13 05:01PM | 4 Winners and 1 Loser from This Weeks Earnings Storm at Wall St. Cheat Sheet |
| 03-May-13 09:18PM | Becton Dickinson: Strengths, Weaknesses, Opportunities, and Threats at Motley Fool |
| 02:31PM | Bear Market Coming? Learn From The Last One at Seeking Alpha |
| 01:30PM | In A Growth-Starved Sector, Becton Dickinson Rules at Investopedia |
| 02-May-13 04:38PM | Becton Dickinson Rises On Unusually High Volume (BDX) at TheStreet |
| 03:01PM | Becton, Dickinson Increases Guidance at Motley Fool |
| 02:00PM | Becton Beats Earnings, Guides High Zacks |
| 01:11PM | How Health Care Is Mining, Using Your Data Big Data Download |
| 01:11PM | How Health Care Is Mining, Using Your Data |
| 01:00PM | Becton, Dickinson and Management Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 09:23AM | This Medical Company Is Not Cheap at Motley Fool |
| 08:22AM | Becton, Dickinson Earnings: Everything You Must Know Now at Wall St. Cheat Sheet |
| 01-May-13 06:32PM | Dividend Aristocrats That Sweep You Off Your Feet at Motley Fool |
| 01:52PM | A Look at Fundamentals Ahead of Upcoming Earnings at Motley Fool |
| 30-Apr-13 04:16PM | Board member bought shares at Edwards Lifesciences at MarketWatch |
| 01:19PM | Forbes Earnings Preview: Becton Dickinson at Forbes |
| 04:25AM | Not All Dividend Increases Are The Same: 2 Dividend Trends That Can Make A Difference at Seeking Alpha |
| 28-Apr-13 12:28PM | Trounce the Market With This Diabetes Care Company at Motley Fool |
| 26-Apr-13 01:03PM | 3 Stocks Pushing The Health Care Sector Lower at TheStreet |
| 24-Apr-13 08:06AM | Keeping Track Of A 30 Stock Dividend Portfolio Can Be Easy at Seeking Alpha |
| 23-Apr-13 08:06AM | InPlay: Becton Dickinson: FDA approves second drug in BD Simplist Prefilled Injectable line of products Briefing.com |
| 08:00AM | FDA Approves Second Drug in BD Simplist Prefilled Injectable Line of Products PR Newswire |
| 21-Apr-13 01:21PM | Finding Stocks to Help You Retire Rich at Motley Fool |
| 19-Apr-13 10:02AM | Buy This Healthcare Outperformer at Motley Fool |
| 18-Apr-13 12:00PM | Baxter Earnings Beat on EPS, Miss on Rev Zacks |
| 17-Apr-13 02:18PM | [$$] Abbott Injects Dose of Optimism at Barrons.com |
| 08:30AM | Nearly 8 Million Healthcare Personnel Come in Contact with Chemotherapy Drugs, According to CDC PR Newswire |
| 16-Apr-13 04:01PM | 1 Pharma Stock to Buy, 1 to Sell at Motley Fool |
| 15-Apr-13 02:54PM | 4 Healthcare Stock Stories For Monday Investment Wellness at Wall St. Cheat Sheet |
| 01:40PM | Becton Receives 510(k) Clearance Zacks |
| 12-Apr-13 01:28PM | Are These 2 Medical Device Stocks Cheap For A Reason? at Motley Fool |
| 08:01AM | BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS Passive Needle Guard CNW Group |
| 11-Apr-13 08:01AM | InPlay: Becton Dickinson receives FDA 510(k) clearance and commercial launch of BD UltraSafe PLUS Passive Needle Guard Briefing.com |
| 08:00AM | BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS Passive Needle Guard PR Newswire |
| 10-Apr-13 04:16PM | Becton, Dickinson And Co. Becomes #29 Most Shorted S&P 500 Component, Replacing Paychex at TheStreet |
| 09-Apr-13 02:20PM | MedAssets in Partnership with Ariba Zacks |
|
|
| Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| BECTON HENRY P JR | Director | May 22 | Sale | 101.86 | 3,117 | 317,498 | 89,541 | May 23 01:54 PM | | Boles Donna M | Senior VP - Human Resources | May 17 | Option Exercise | 71.72 | 8,251 | 591,762 | 22,858 | May 20 10:27 AM | | Boles Donna M | Senior VP - Human Resources | May 17 | Sale | 101.38 | 2,415 | 244,833 | 14,607 | May 20 10:27 AM | | COHEN GARY M | Executive Vice President | May 13 | Option Exercise | 59.16 | 21,353 | 1,263,243 | 87,930 | May 14 10:16 AM | | COHEN GARY M | Executive Vice President | May 13 | Sale | 100.22 | 8,753 | 877,226 | 66,577 | May 14 10:16 AM | | SHERMAN JEFFREY S | Sr. VP and General Counsel | May 07 | Option Exercise | 59.16 | 15,017 | 888,406 | 40,193 | May 08 12:10 PM | | SHERMAN JEFFREY S | Sr. VP and General Counsel | May 07 | Sale | 97.42 | 5,899 | 574,681 | 25,176 | May 08 12:10 PM | | COHEN GARY M | Executive Vice President | May 03 | Option Exercise | 54.41 | 23,177 | 1,261,061 | 89,754 | May 06 03:43 PM | | COHEN GARY M | Executive Vice President | May 03 | Sale | 96.74 | 23,177 | 2,242,226 | 66,577 | May 06 03:43 PM | | Lim James C | Senior Vice President | Mar 15 | Option Exercise | 63.66 | 6,404 | 407,654 | 10,265 | Mar 18 03:34 PM | | Lim James C | Senior Vice President | Mar 15 | Sale | 92.15 | 1,983 | 182,733 | 6,262 | Mar 18 03:34 PM | | BECTON HENRY P JR | Director | Mar 11 | Option Exercise | 84.04 | 1,802 | 151,440 | 92,658 | Mar 12 05:04 PM | | FORLENZA VINCENT A | Chairman, CEO and President | Feb 20 | Option Exercise | 38.78 | 26,000 | 1,008,280 | 134,724 | Feb 21 12:50 PM | | FORLENZA VINCENT A | Chairman, CEO and President | Feb 20 | Sale | 87.92 | 26,000 | 2,285,920 | 108,724 | Feb 21 12:50 PM | | Sichak Stephen | Senior Vice President | Feb 15 | Option Exercise | 59.16 | 8,916 | 527,471 | 16,271 | Feb 20 08:39 AM | | Sichak Stephen | Senior Vice President | Feb 15 | Sale | 88.34 | 2,937 | 259,455 | 7,355 | Feb 20 08:39 AM | | ORR JAMES F | Director | Feb 11 | Option Exercise | 53.02 | 4,436 | 235,211 | 24,044 | Feb 12 01:48 PM | | ORR JAMES F | Director | Feb 11 | Sale | 88.28 | 4,436 | 391,610 | 19,608 | Feb 12 01:48 PM | | SCOTT BERTRAM L | Director | Feb 08 | Option Exercise | 32.07 | 2,781 | 89,187 | 21,389 | Feb 11 02:22 PM | | SHERMAN JEFFREY S | Sr. VP and General Counsel | Feb 07 | Option Exercise | 54.41 | 16,301 | 886,937 | 41,477 | Feb 08 11:18 AM | | SHERMAN JEFFREY S | Sr. VP and General Counsel | Feb 07 | Sale | 87.30 | 16,301 | 1,423,077 | 25,176 | Feb 08 11:18 AM | | KOZY WILLIAM A | Executive Vice President | Feb 06 | Option Exercise | 54.41 | 22,923 | 1,247,240 | 124,013 | Feb 07 02:35 PM | | Boles Donna M | Senior VP - Human Resources | Feb 06 | Option Exercise | 59.16 | 9,855 | 583,022 | 24,462 | Feb 08 11:27 AM | | Boles Donna M | Senior VP - Human Resources | Feb 06 | Sale | 87.59 | 3,201 | 280,376 | 14,607 | Feb 08 11:27 AM | | KOZY WILLIAM A | Executive Vice President | Feb 06 | Sale | 87.56 | 22,923 | 2,007,138 | 101,090 | Feb 07 02:35 PM | | BECTON HENRY P JR | Director | Dec 12 | Sale | 78.49 | 850 | 66,717 | 91,896 | Dec 13 09:26 AM | | Sichak Stephen | Senior Vice President | Dec 10 | Option Exercise | 54.41 | 7,641 | 415,747 | 19,050 | Dec 12 11:54 AM | | Sichak Stephen | Senior Vice President | Dec 10 | Sale | 77.71 | 7,641 | 593,782 | 11,409 | Dec 12 11:54 AM | | BECTON HENRY P JR | Director | Dec 07 | Sale | 77.44 | 850 | 65,824 | 92,746 | Dec 10 10:49 AM | | BECTON HENRY P JR | Director | Nov 30 | Sale | 76.62 | 850 | 65,127 | 93,596 | Dec 03 10:15 AM | | BECTON HENRY P JR | Director | Nov 21 | Option Exercise | 32.07 | 2,781 | 89,187 | 97,227 | Nov 26 02:23 PM | | BECTON HENRY P JR | Director | Nov 21 | Sale | 76.27 | 2,781 | 212,107 | 94,446 | Nov 26 02:23 PM | | Elkins David V | Executive VP and CFO | Nov 08 | Sale | 75.17 | 3,602 | 270,762 | 5,513 | Nov 13 08:11 AM | | Boles Donna M | Senior VP - Human Resources | Aug 28 | Option Exercise | 54.41 | 5,731 | 311,824 | 18,221 | Aug 29 01:31 PM | | Boles Donna M | Senior VP - Human Resources | Aug 28 | Sale | 76.80 | 5,731 | 440,163 | 12,490 | Aug 29 01:31 PM | | SOMMER ALFRED | Director | Aug 08 | Sale | 75.38 | 4,436 | 334,386 | 16,228 | Aug 09 10:44 AM | | SHERMAN JEFFREY S | Sr. VP and General Counsel | Aug 03 | Sale | 74.93 | 22,438 | 1,681,279 | 20,908 | Aug 06 12:36 PM |
|
|
|
|
|
|
